94 related articles for article (PubMed ID: 20483386)
1. Sirolimus has a potential to influent viral recurrence in HCV positive liver transplant candidates.
Wagner D; Kniepeiss D; Schaffellner S; Jakoby E; Mueller H; Fahrleitner-Pammer A; Stiegler P; Tscheliessnigg KH; Iberer F
Int Immunopharmacol; 2010 Aug; 10(8):990-3. PubMed ID: 20483386
[TBL] [Abstract][Full Text] [Related]
2. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
[TBL] [Abstract][Full Text] [Related]
3. Calcineurin inhibition and disease recurrence in the hepatitis C virus-positive liver transplant recipient.
Pollard S
Liver Int; 2004 Oct; 24(5):402-6. PubMed ID: 15482334
[TBL] [Abstract][Full Text] [Related]
4. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
[TBL] [Abstract][Full Text] [Related]
5. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
[TBL] [Abstract][Full Text] [Related]
6. Recurrent and new hepatitis C virus infection after liver transplantation.
Everhart JE; Wei Y; Eng H; Charlton MR; Persing DH; Wiesner RH; Germer JJ; Lake JR; Zetterman RK; Hoofnagle JH
Hepatology; 1999 Apr; 29(4):1220-6. PubMed ID: 10094968
[TBL] [Abstract][Full Text] [Related]
7. Long-term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantation.
Di Martino V; Saurini F; Samuel D; Gigou M; Dussaix E; Reynès M; Bismuth H; Féray C
Hepatology; 1997 Nov; 26(5):1343-50. PubMed ID: 9362382
[TBL] [Abstract][Full Text] [Related]
8. Tissue quantification of hepatitis C virus RNA with morphologic correlation in the diagnosis of recurrent hepatitis C virus in human liver transplants.
Aardema KL; Nakhleh RE; Terry LK; Burd EM; Ma CK; Moonka DK; Brown KA; Abouljoud MS
Mod Pathol; 1999 Nov; 12(11):1043-9. PubMed ID: 10574601
[TBL] [Abstract][Full Text] [Related]
9. Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation.
D'Errico-Grigioni A; Fiorentino M; Vasuri F; Gruppioni E; Fabbrizio B; Zucchini N; Ballardini G; Morelli C; Pinna AD; Grigioni WF
Liver Transpl; 2008 Mar; 14(3):313-20. PubMed ID: 18306349
[TBL] [Abstract][Full Text] [Related]
10. Exploring the bidirectional interactions between human cytomegalovirus and hepatitis C virus replication after liver transplantation.
Nebbia G; Mattes FM; Cholongitas E; Garcia-Diaz A; Samonakis DN; Burroughs AK; Emery VC
Liver Transpl; 2007 Jan; 13(1):130-5. PubMed ID: 17192909
[TBL] [Abstract][Full Text] [Related]
11. Predictors of patient and graft survival following liver transplantation for hepatitis C.
Charlton M; Seaberg E; Wiesner R; Everhart J; Zetterman R; Lake J; Detre K; Hoofnagle J
Hepatology; 1998 Sep; 28(3):823-30. PubMed ID: 9731579
[TBL] [Abstract][Full Text] [Related]
12. [Long-term consequences of co-infection by hepatitis G virus in hepatitis c virus infected kidney transplant patients].
Rostaing L; Izopet J; Arnaud C; Rumeau JL; Duffaut M; Cisterne JM; Durand D
Nephrologie; 1999; 20(3):165-70. PubMed ID: 10418007
[TBL] [Abstract][Full Text] [Related]
13. Sirolimus conversion may suppress viral replication in hepatitis C virus-positive renal transplant candidates.
Soliman A; Fathy A; Khashab S; Shaheen N; Soliman M
Exp Clin Transplant; 2013 Oct; 11(5):408-11. PubMed ID: 24128134
[TBL] [Abstract][Full Text] [Related]
14. An assessment of interactions between hepatitis C virus and herpesvirus reactivation in liver transplant recipients using molecular surveillance.
Humar A; Washburn K; Freeman R; Paya CV; Mouas H; Alecock E; Razonable RR;
Liver Transpl; 2007 Oct; 13(10):1422-7. PubMed ID: 17902128
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of hepatitis C infection after liver transplantation.
Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
[TBL] [Abstract][Full Text] [Related]
16. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate.
Pelletier SJ; Raymond DP; Crabtree TD; Berg CL; Iezzoni JC; Hahn YS; Sawyer RG; Pruett TL
Hepatology; 2000 Aug; 32(2):418-26. PubMed ID: 10915752
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus reactivation in anti-hepatitic C virus-positive renal transplant recipients.
Melon S; Galarraga MC; Villar M; Laures A; Boga JA; de Oña M; Gomez E
Transplant Proc; 2005 Jun; 37(5):2083-5. PubMed ID: 15964345
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
Moya A; Berenguer M; Aguilera V; Juan FS; Nicolás D; Pastor M; López-Andujar R; Rayón M; Orbis F; Mora J; De Juan M; Carrasco D; Vila JJ; Prieto M; Berenguer J; Mir J
Liver Transpl; 2002 Nov; 8(11):1020-7. PubMed ID: 12424715
[TBL] [Abstract][Full Text] [Related]
20. High levels of hepatitis C virus RNA in native livers correlate with the development of cholestatic hepatitis in liver allografts and a poor outcome.
Deshpande V; Burd E; Aardema KL; Ma CK; Moonka DK; Brown KA; Abouljoud MS; Nakhleh RE
Liver Transpl; 2001 Feb; 7(2):118-24. PubMed ID: 11172395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
